Toceranib phosphate for the treatment of dogs with high‐risk adrenal gland tumours: 16 cases (2019‐2023)
Toceranib may offer clinical benefit and improve outcome in dogs with high-risk ATs in both the macroscopic and microscopic disease setting.
Authors
- Luciano Pisoni
- Giulia Ghisoni (ORCID: https://orcid.org/0000-0003-3386-2582)
- Francesca Del Baldo (ORCID: https://orcid.org/0000-0002-5577-0657)
- Carmit Chalfon (ORCID: https://orcid.org/0000-0002-3062-4303)
- Antonio Maria Tardo (ORCID: https://orcid.org/0009-0009-3636-0415)
- Federico Fracassi (ORCID: https://orcid.org/0000-0003-3121-2199)
- Riccardo Finotello (ORCID: https://orcid.org/0000-0002-1932-211X)
- Laura Marconato (ORCID: https://orcid.org/0000-0002-7843-615X)
- Maurice M.J.M. Zandvliet (ORCID: https://orcid.org/0000-0002-0542-5433)
- Sara Galac (ORCID: https://orcid.org/0000-0001-9159-5596)
Institutions
- Utrecht University (NL)
- Environment Park (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Journal of Small Animal Practice
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1111/jsap.13840
- Citations
- 2
- Primary Topic
- Veterinary Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04